Novartis Agrees to Buy Rest of Alcon From Nestle, Shareholders

[guest]

Novartis AG offered to buy the rest of Alcon Inc., the world’s largest eye-care company, from Nestle SA and shareholders for a total of $39.3 billion, as Chief Executive Officer Daniel Vasella expands into products for eye surgery.


More...

Toggle signature
||||| Mentor Group Access Now! |||||